CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanxi Zhendong Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanxi Zhendong Pharmaceutical Co Ltd
Zhendong Technology Park
Guangming South Road, Changzhi County
Phone: +86 3558096012p:+86 3558096012 CHANGZHI, SHX  047100  China Ticker: 300158300158
Business Summary
Shanxi Zhendong Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, production and sale of Chinese patent drugs, chemical raw materials and preparations. The Company's main products include anti-tumor series, cardiovascular and cerebrovascular series, anti-infection series, digestive system series, vitamin nutrition series, respiratory system series, antipyretic analgesic series and nervous system series. The Company is also involved in the cultivation of medicinal herbs, as well as the wholesale and retail of pharmaceutical products. The Company distributes its products in domestic market, with North China market as its main market.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board AnpingLi 60 5/29/2023
Executive President, Deputy General Manager ZhenhongLei 48 3/29/2022
President, Director LianminYang 59 4/14/2023 12/2/2021
9 additional Officers and Directors records available in full report.

Business Names
Business Name
300158
Kangyuan Pharmaceutical

General Information
Number of Employees: 3,693 (As of 12/31/2022)
Outstanding Shares: 1,027,494,660 (As of 9/30/2023)
Shareholders: 78,387
Stock Exchange: SHE
Fax Number: +86 3558096018


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024